Skip to main content
Premium Trial:

Request an Annual Quote

Age Labs Gets €1M From Research Council of Norway

NEW YORK (GenomeWeb) – Age Labs, an Oslo-based biomarker discovery company, has been awarded €1 million (about $1.1 million) in R&D funding from the Research Council of Norway to support the development of a unique biomarker for aging.

Specifically, the company is developing a methylated DNA biomarker that will predict all-cause mortality risk and risk of developing certain age-related diseases. The company expects the biomarker to enable pharmaceutical companies to increase the probability of success in clinical trials by providing more accurate risk information about patients participating in the trials.

Age Labs is leading the four-year project, which includes collaborators AbbVie, Fürst Medical Laboratory, the Norwegian Institute of Public Health, and Oslo University.

According to its website, Age Labs applies machine learning techniques on large epigenetic datasets from Norwegian and international biobanks.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.